Market
Will GPT-4b micro extend human lifespan by 10 years by 2030?
4
Resolution / Starting Odds
Yes • 50%
No • 50%
Scientific publications or official statements from OpenAI or Retro Biosciences
Story
OpenAI's GPT-4b Micro Model Aims to Extend Life by 10 Years with Yamanaka Factors
Jan 17, 2025, 11:50 PM
OpenAI has developed a new AI model named GPT-4b micro in collaboration with Retro Biosciences, a longevity science startup, aimed at extending human lifespan by up to 10 years. The model focuses on engineering proteins, specifically the Yamanaka factors, which can transform adult human skin cells into stem cells. Preliminary tests suggest that the redesigned proteins are more than 50 times as effective as their natural counterparts in this cellular reprogramming process. This project marks OpenAI's first foray into biological data and scientific discovery, with the potential to revolutionize regenerative medicine and organ development. The collaboration was initiated a year ago, with Retro Biosciences being backed by a $180 million investment from Sam Altman, OpenAI's CEO. The model differs from Google's AlphaFold, which predicts protein structures, by focusing on protein interactions and function enhancement.
View original story
Similar markets
Yes • 50%
No • 50%
Other • 25%
Cellular reprogramming • 25%
Genetic modification • 25%
Drug discovery • 25%
Disease prevention • 25%
Cellular rejuvenation • 25%
Anti-aging treatments • 25%
Other • 25%
6-8 discoveries • 25%
More than 8 discoveries • 25%
0-2 discoveries • 25%
3-5 discoveries • 25%
Reduced disease incidence • 25%
Other • 25%
Improved cellular health • 25%
Increased lifespan • 25%
Healthcare • 25%
Other • 25%
Energy • 25%
Agriculture • 25%
Yes • 50%
No • 50%
